Bayer's Skyla pregnancy prevention system approved by FDA Bayer announced that the FDA approved Skyla (levonorgestrel-releasing intrauterine system) 13.5 mg, a new hormone-releasing system that is placed in the uterus for the prevention of pregnancy for up to three years. Skyla is a small, flexible plastic T-shaped device containing 13.5 mg of a progestin hormone called levonorgestrel. Skyla is intended for long-term use for up to three years but may be removed by a healthcare provider at any time.
News For BAYRY From The Last 14 Days
Check below for free stories on BAYRY the last two weeks.
Bayer non-cystic fibrosis bronchiectasis treatment gets FDA orphan designation According to a post on the FDA's website, Bayer's ciprofloxacin dry powder inhaler to treat non-cystic fibrosis bronchiectasis received orphan designation. Reference Link